Our GHK-Cu pen holds 50 mg in 3 ml as a pre-loaded multi-dose pen. The important thing about a GHK-Cu product is that it contains the defined complex of GHK and copper(II), and that the quantity is documented per batch rather than asserted. We do not ask you to take that on trust: for every batch we publish the independent certificate of analysis on our certificates page.
GHK-Cu is chemically well described. The clinical evidence depends heavily on formulation and route, and this is where most pages about it overreach. Cell and animal models examined collagen markers and wound healing. Small human studies concerned topical programmes or a specific wound gel. None of that establishes results for an injectable pen, and we say so ourselves. Stimulation of collagen synthesis in fibroblast cultures by GHK-Cu. PMID 3169264; GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. PMC4508379; The potential of GHK as an anti-aging peptide. PMC8789089; The human tripeptide GHK and tissue remodeling. PMID 18644225
What GHK-Cu actually is
GHK stands for glycyl-L-histidyl-L-lysine, a tripeptide of three amino acids. It binds copper(II), and under physiological conditions the literature supports a defined 1:1 coordination complex. GHK-Cu is therefore not “copper plus a peptide”: it is a specific complex, and its behaviour follows from that.
It was isolated in 1973 by Pickart as an activity in human albumin. The molecule occurs naturally in human plasma, and reported levels decline with age: an average around 200 ng/ml at age 20 falling to roughly 80 ng/ml by 60. That decline is the observation the regenerative interest is built on, and the reason it appears under peptides for longevity.
Natural occurrence is not a safety argument. That a molecule exists in plasma at nanogram concentrations does not establish the safety of a manufactured, far more concentrated, differently administered form. That distinction is worth holding onto when reading any page about this compound, including this one.
What the laboratory evidence shows
The best-characterised finding is on collagen synthesis in fibroblast culture. Stimulation begins somewhere between 10⁻¹² and 10⁻¹¹ M and reaches a maximum around 10⁻⁹ M, a very low concentration, and one of the reasons the compound attracted attention.
Reviews describe GHK modulating both synthesis and breakdown of collagen and glycosaminoglycans, and influencing metalloproteinases and their inhibitors. It is described as a modulator of several pathways rather than a single-target agonist, which is a different kind of mechanism from most compounds in this catalogue.
These are cell and animal findings. They describe what the molecule does in a dish or a rodent, and that is where their claim ends.
Where the evidence stops
Human work on GHK-Cu has concerned topical skincare programmes and a specific wound gel. Those studies address the formulations they used. They do not establish wrinkle reduction, hair growth, or the benefit and long-term safety of an injectable pen. Pages that cite topical results underneath an injectable product are borrowing evidence that does not transfer.
Formulation is not incidental here. Properties depend on pH, concentration, counter-ions and the rest of the preparation, so a cosmetic serum, a clinically studied wound gel and an injectable solution are three different products. We set this out in full at GHK-Cu injectable vs topical copper peptides.
For a topical product there is also a penetration question: whether a peptide-sized molecule crosses the stratum corneum in meaningful quantity. Injection removes that question and removes the barrier along with it. Neither route is straightforwardly better; they trade different problems.
What the certificate shows
An independent laboratory tests every batch for identity by mass spectrometry, for purity by HPLC and for sterility. The certificate for your batch shows the HPLC purity figure and the concentration of the cartridge, in mg/ml and as total mg per 3 ml, under the batch number printed on the pen in your hand. Those are the figures that matter most for an injectable: what the molecule is, how much of it there is, how pure it is, and that the solution is sterile. How identity and purity are established by different analytical methods is explained separately.
Pharmacopoeial practice for a metal–peptide complex can go further, for instance by stating the exact designation of the complex or salt, or by confirming the copper content and its ratio to the peptide. It is useful to know that such tests exist. They are not a reason to distrust a certificate that reports purity and content for a named batch. More on reading these documents at how to read a certificate of analysis and batch and lot matching.
Regulatory position
GHK-Cu holds no marketing authorisation as a medicine. Topical cosmetic formulations containing it are regulated as cosmetics, a different framework with different requirements. Cosmetic regulation is not a medicines assessment and does not evaluate injectable use.
Related reading: what is GHK-Cu?, cosmetic peptides, peptides for skin, and the Vitality Stack and Elite Repair Stack, the two sets that include this pen.
